You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DAC

Showing 1 - 25 of 251
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelodysplastic Syndrome, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning Trial in Guangzhou (Granulocyte

Recruiting
  • Myelodysplastic Syndrome
  • +2 more
  • Granulocyte Colony-Stimulating Factor(G-CSF)
  • +5 more
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Jul 11, 2022

Secondary Acute Myeloid Leukemia Evolving From MDS, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning Trial in

Recruiting
  • Secondary Acute Myeloid Leukemia Evolving From MDS
  • +2 more
  • Granulocyte Colony-Stimulating Factor(G-CSF)
  • +4 more
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
Jul 5, 2022

Post-acute COVID-19 Syndrome Trial in Paris, Saint-Denis, Suresnes (Training in the management of functional disorders,

Not yet recruiting
  • Post-acute COVID-19 Syndrome
  • Training in the management of functional disorders
  • Reimbursement of 3 long consultations
  • Paris, France
  • +6 more
Oct 18, 2023

Incontinence-associated Dermatitis Trial in Berlin (ESENTA™ Skin Barrier Spray (ConvaTec, UK), Hydrophobes Basisgel DAC)

Recruiting
  • Incontinence-associated Dermatitis
  • ESENTA™ Skin Barrier Spray (ConvaTec, UK)
  • Hydrophobes Basisgel DAC
  • Berlin, Germany
    Charité Universitätsmedizin Berlin
Oct 28, 2022

COVID-19 Trial in France (usual care and follow-up by a nurse, Personalized Multifactorial Intervention (IMP))

Not yet recruiting
  • COVID-19
  • usual care and follow-up by a nurse
  • Personalized Multifactorial Intervention (IMP)
  • Lyon, France
  • +3 more
Mar 24, 2023

Quantitative 3-Dimensional Chest CT Vascular Reconstruction

Recruiting
  • Pulmonary Embolism
  • Contrast-enhanced chest CT
  • Boston, Massachusetts
    Brigham and Women's Hospital
Apr 5, 2022

Plasma Biomarkers P-DAC, V1

Terminated
  • Pancreatic Ductal Adenocarcinoma
    • Bracken Rd, Sandyford Industrial Estate, Dublin 18, Ireland
    • +8 more
    Jan 14, 2022

    Acute Myeloid Leukemia Trial in Poland, United States (A arm (DA-90), B arm (DAC), A arm (CLAG-M))

    Recruiting
    • Acute Myeloid Leukemia
    • A arm (DA-90)
    • +3 more
    • New York, New York
    • +9 more
    Sep 30, 2021

    Myelodysplastic Syndrome, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning Trial in Guangzhou (Granulocyte

    Recruiting
    • Myelodysplastic Syndrome
    • +2 more
    • Granulocyte Colony-Stimulating Factor(G-CSF)
    • +4 more
    • Guangzhou, Guangdong, China
      Department of Hematology,Nanfang Hospital, Southern Medical Univ
    Jan 15, 2021

    Recurrent/Refractory Acute Myeloid Leukemia, MDS Trial in ChengDu (TQB2618 injection azacitidine, AZA decitabine, DAC)

    Recruiting
    • Recurrent/Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes
    • TQB2618 injection azacitidine, AZA decitabine, DAC
    • ChengDu, Sichuan, China
      West China Hospital of Sichuan University
    Jun 16, 2022

    Hip Prosthesis Infection Trial in France (Defensive Antiadhesive Coating DAC®, Novagenit SRL)

    Recruiting
    • Hip Prosthesis Infection
    • Defensive Antiadhesive Coating DAC®, Novagenit SRL
    • Amiens, France
    • +13 more
    Dec 13, 2022

    P53 Mutation, Myeloid Malignancy, MDS Trial in Shanghai (Decitabine, Arsenic Trioxide)

    Recruiting
    • P53 Mutation
    • +3 more
    • Shanghai, Shanghai, China
      Hematological department, Shanghai Institute of Hematology, Ruij
    Apr 20, 2021

    Response Rate Trial in Shanghai (Decitabine)

    Completed
    • Response Rate
    • Shanghai, Shanghai, China
      Blood & Marrow Transplantation Center, RuiJin Hospital
    May 19, 2021

    Comparative Bioavailability Trial in Erfurt (GLA-015, DAC C-052 "Cannabidiol" / NRF 22.10 "Oily cannabidiol solution 100 mg/ml")

    Completed
    • Comparative Bioavailability
    • GLA-015
    • DAC C-052 "Cannabidiol" / NRF 22.10 "Oily cannabidiol solution 100 mg/ml"
    • Erfurt, Thuringia, Germany
      SocraTec R&D GmbH Clinical Pharmacology Unit
    Jul 12, 2021

    PTSD (PTSD) Trial in New York (Ketamine, Midazolam)

    Completed
    Has Results
    • Posttraumatic Stress Disorder (PTSD)
    • New York, New York
      Depression and Anxiety Center (DAC)
    Feb 16, 2021

    Leukemia Trial in Houston (Decitabine, Azacitidine)

    Completed
    Has Results
    • Leukemia
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Dec 1, 2020

    Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia Trial in Philadelphia, Houston (Decitabine,

    Completed
    • Acute Myeloid Leukemia
    • +2 more
    • Philadelphia, Pennsylvania
    • +1 more
    May 18, 2021

    Leukemia Trial in United States (Azacitidine (AZA) Days 1 - 3, Decitabine (DAC), Best Supportive Care (BSC))

    Active, not recruiting
    • Leukemia
    • Azacitidine (AZA) Days 1 - 3
    • +3 more
    • Tampa, Florida
    • +5 more
    Jul 21, 2020

    Primary Myelofibrosis, Post-Polycythemia Vera, Post-Essential Thrombocytopenia Trial in United States (Panobinostat)

    Terminated
    Has Results
    • Primary Myelofibrosis
    • +2 more
    • Scottsdale, Arizona
    • +8 more
    Jul 9, 2021

    Solid Tumors Trial in United States (INCB053914, I-DAC (Intermediate dose cytarabine), Azacitidine)

    Terminated
    Has Results
    • Solid Tumors
    • Tucson, Arizona
    • +18 more
    Nov 9, 2021

    MDS Trial in France (Decitabine, HYDROXYUREA)

    Completed
    • MDS
    • Saint-Denis, La Réunion, France
    • +44 more
    Nov 17, 2021

    Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting Trial run by the NINDS (DAC-HYP)

    Completed
    • Multiple Sclerosis
    • Multiple Sclerosis, Relapsing-Remitting
    • DAC-HYP
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Oct 31, 2019

    Sofosbuvir/Daclatasvir in HCV-infected Lactating Women

    Recruiting
    • Hepatitis C Virus Infection
    • Pharmacokinetic test
    • Cairo, Non-US, Egypt
      Faculty of Medicine Ain Shams University Research Institute- Cli
    Aug 21, 2022

    Renal Cell Carcinoma, Soft Tissue Sarcoma, Metastatic Disease Trial in Richmond (AR-42, Pazopanib)

    Terminated
    Has Results
    • Renal Cell Carcinoma
    • +2 more
    • Richmond, Virginia
      Virginia Commonwealth University/Massey Cancer Center
    Oct 3, 2019

    Depression, Mild Cognitive Impairment Trial in New York (IV Ketamine)

    Recruiting
    • Depression
    • Mild Cognitive Impairment
    • IV Ketamine
    • New York, New York
      Icahn School of Medicine at Mount Sinai (Depression and Anxiety
    Sep 29, 2023